Galapagos NV
GLPG
#4563
Rank
$2.11 B
Marketcap
$31.59
Share price
-0.57%
Change (1 day)
17.04%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : $4.12 Billion USD

According to Galapagos NV's latest financial reports the company's total assets are $4.12 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$4.30 B-10.65%
2023-12-31$4.81 B-5.15%
2022-12-31$5.07 B-13.65%
2021-12-31$5.88 B-16.37%
2020-12-31$7.03 B3.45%
2019-12-31$6.79 B312.82%
2018-12-31$1.64 B6.7%
2017-12-31$1.54 B35.44%
2016-12-31$1.13 B135.51%
2015-12-31$0.48 B47.09%
2014-12-31$0.32 B-17.11%
2013-12-31$0.39 B27.49%
2012-12-31$0.31 B48.83%
2011-12-31$0.20 B-18.93%
2010-12-31$0.25 B25.3%
2009-12-31$0.20 B23.95%
2008-12-31$0.16 B-23.5%
2007-12-31$0.21 B-1.83%
2006-12-31$0.22 B128.95%
2005-12-31$96.61 M356.2%
2004-12-31$21.17 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
$114.45 B 2,677.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
$192.81 B 4,578.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$152.32 B 3,595.81%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
$133.89 B 3,148.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
$0.15 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$84.18 B 1,942.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$39.85 B 867.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$82.46 B 1,900.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$129.54 B 3,043.15%๐Ÿ‡บ๐Ÿ‡ธ USA